Table 2. Gene expression analysis at 1q and correlation with copy number gain.
| Consensus segment | Clone ID on the chip | Hugo gene symbol | Gene name | Localisation (start–end) (bp) | Cytoband | P-value 1 | P-value 2 |
|---|---|---|---|---|---|---|---|
| G1 | pdzk1 | PDZK1 | PDZ domain containing 1 | 143403500–143439848 | 1q21.1 | 0.015 | |
| G1 | h2bfq | HIST2H2BE | Histone 2, H2be | 146631105–146633327 | 1q21.2 | ||
| G1 | cra | MTMR11 | Myotubularin-related protein 11 | 146675639–146683822 | 1q21.2 | 0.09 | 0.011 |
| G1 | vps45b | VPS45A | Vacuolar protein sorting 45A | 146814958–146892599 | 1q21.2 | 0.025 | 0.027 |
| G1 | ca14 | CA14 | Carbonic anhydrase XIV | 147005313–147012571 | 1q21.2 | 0.019 | |
| G1 | ensa | ENSA | Endosulfine alpha | 147370158–147377163 | 1q21.3 | 0.05 | 0.025 |
| G1 | anxa9 | ANXA9 | Annexin A9 | 147729649–147743202 | 1q21.3 | ||
| G1 | af1q | MLLT11 | Myeloid/lymphoid or mixed-lineage leukaemia; translocated to, 11 | 147807778–147816066 | 1q21.3 | 0.045 | |
| G1 | pip5k1a | PIP5K1A | Phosphatidylinositol-4-phosphate 5-kinase, type I, alpha | 147897780–147948713 | 1q21.3 | 0.09 | |
| G2 | mtx1 | MTX1 | Metaxin 1 | 151952587–151957144 | 1q22 | 0.051 | |
| G2 | c1orf2 | C1orf2 | Chromosome 1 open reading frame 2 | 151994882–152003120 | 1q22 | ND | ND |
| G2 | hspc003 | MAPBPIP | Mitogen-activated protein-binding protein-interacting protein | 152802478–152806168 | 1q22 | 0.076 | |
| G2 | RAB25 | RAB25, member RAS oncogene family | 152808855–152818122 | 1q22 | 0.001 | ||
| G2 | cct3 | CCT3 | Chaperonin containing TCP1, subunit 3 (gamma) | 153056634–153085846 | 1q22 | 0.0003 | |
| G2 | croc4 | C1orf61 | Chromosome 1 open reading frame 61 | 153128056–153153185 | 1q22 | 0.075 | |
| G3 | usf1 | USF1 | Upstream transcription factor 1 | 157781513–157787199 | 1q23.3 | 0.009 | 0.007 |
| G3 | aldh9 | ALDH9A1 | Aldehyde dehydrogenase 9 family, member A1 | 162327485–162364132 | 1q24.1 | 0.088 | 0.022 |
| G3 | mpzl1 | MPZL1 | Myelin protein zero-like 1 | 164387268–164453994 | 1q24.2 | 0.05 | 0.070 |
| G3 | tbx19 | TBX19 | T-box 19 | 164946309–164979694 | 1q24.2 | 0.027 | |
| G4 | plu-1 | JARID1B | Jumonji, AT rich interactive domain 1B (RBP2-like) | 199162987–199245053 | 1q32.1 | 0.097 | 0.095 |
| G4 | sox13 | SOX13 | SRY (sex determining region Y)-box 13 | 200442674–200457500 | 1q32.1 | ||
| G4 | pctk3 | PCTK3 | PCTAIRE protein kinase 3 | 201857380–201862760 | 1q32.1 | 0.05 | 0.001 |
| G5 | spuf | NENF | Neuron-derived neurotrophic factor | 209222493–209235935 | 1q32.3 | 0.023 | |
| G5 | esrrg | ESRRG | Oestrogen-related receptor gamma | 212723109–213309462 | 1q41 | ||
| G6 | arf1 | ARF1 | ADP-ribosylation factor 1 | 224655969–224672451 | 1q42.13 | 0.098 | |
| G6 | rab4 | RAB4A | RAB4A, member RAS oncogene family | 225806272–225839911 | 1q42.13 | 0.020 | |
| G6 | disc1 | DISC1 | Disrupted in schizophrenia 1 | 228235748–228635487 | 1q42.2 | 0.001 | |
| G6 | tarbp1 | TARBP1 | TAR (HIV) RNA-binding protein 1 | 230818923–230906713 | 1q42.2 | 0.0009 | |
| G6 | tbce | TBCE | Tubulin-specific chaperone e | 231749924–231831433 | 1q42.3 | ||
| G6 | chs1 | LYST | Lysosomal trafficking regulator | 232120934–232326807 | 1q42.3 | 0.010 | |
| G7 | hnrpu | HNRPU | Heterogeneous nuclear ribonucleoprotein U | 241218474–241229338 | 1q44 | ND | ND |
ND=not done and refers to Q–RT–PCR measurements which could not be performed.
RNA expression profiles of 307 genes located at 1q were analysed in a total of 29 breast cancer cell lines and 26 primary tumours. Genes presented correspond to the 30 genes selected by DS. Significance threshold was DS>0.32 corresponding to <0.01 false positive. Expression levels were quantified by Q–RT–PCR for 28 out of 30 genes (primer design was unsuccessful for c1orf2 and HNRPU). Quantitative PCR primer sequences are presented in Supplementary Table S2. The recently reported candidate oncogene RAB25, which was not present on our array, was quantified as a positive control. Quantitative RT–PCR data were analysed for differential expression using two t-test approaches; t-test 1 (noted P-value 1) indicates correlation with copy number gain; t-test 2 (P-value 2) differential expression with normal breast. Two significance thresholds were used; strict P=<0.05, tolerant P=<0.1, P-values>0.1 were considered as nonsignificant and only values within the tolerance limit are indicated. Cell lines analysed were: BRCAMZ01, MDAMB175, CAL51, MDAMB435, SKBR7, ZR7530, BT474, MCF7Rich, HS578T, MDAMB436, SUM149, SUM185, BT20, HCC1187, HCC1428, HCC1937, HCC1954, HCC2218, MDAMB157, MDAMB361, MDAMB468, SKBR3, T47D, UACC812 and ZR751.